SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " doll " 1,593 found 🔀 AI-powered Shuffle
NYC's AI-powered private school's second location guarantees students will graduate with million-dollar business
Dolly Parton Is ‘Trying to Do Too Much Too Soon’ Amid Health Issues: She’s ‘Still Very Unsteady’
Trump took in about $1.2 billion from crypto businesses last year, financial disclosure shows
President Donald Trump took in nearly $1.2 billion dollars from his crypto businesses last year, a federal filing released Tuesday shows, locking in profits while his investors were socked with losses.
Trump took in about $1.2 billion from crypto businesses last year, financial disclosure shows
President Donald Trump took in nearly $1.2 billion dollars from his crypto businesses last year, a federal filing released Tuesday shows, locking in profits while his investors were socked with losses.
Trump made hundreds of millions from cryptocurrency ventures in first year back in office
President Donald Trump collected billions of dollars through an array of cryptocurrency holdings, royalty payments and property investments last year, according to his latest annual financial disclosure released on Tuesday.
Iowa small businesses encouraged to compete for federal defense contracts
Iowa small business owners are being encouraged to compete for billions of dollars in government contracts as the federal government looks to expand its defense industrial base.
Iowa small businesses encouraged to compete for federal defense contracts
Iowa small business owners are being encouraged to compete for billions of dollars in government contracts as the federal government looks to expand its defense industrial base.
Trump filing shows he took in about $1.2 billion from crypto businesses last year
NEW YORK (AP) — President Donald Trump took in nearly $1.2 billion dollars from his crypto businesses last year, a federal filing released Monday shows.
Trump filing shows he took in about $1.2 billion from crypto businesses last year
President Donald Trump took in nearly $1.2 billion dollars from his crypto businesses last year, a federal filing released Monday shows.
Trump filing shows he took in about $1.2 billion from crypto businesses last year
President Donald Trump took in nearly $1.2 billion dollars from his crypto businesses last year, a federal filing released Monday shows.
Trump filing shows he took in about $1.2 billion from crypto businesses last year
President Donald Trump took in nearly $1.2 billion dollars from his crypto businesses last year, a federal filing released Monday shows.
Program looks to help with cost of childcare in New York
Major counties are seeing multimillion-dollar boosts.
Wauwatosa business calls for lawmakers to save hemp
In November, most hemp in Wisconsin will be illegal. Wisconsin's estimated $700 million-dollar industry will shut down.
Reviews clear Telescope Health of fraud allegations; officials encourage Jacksonville residents to use HealthLink JAX
Multiple reviews have found no evidence of fraud, criminal wrongdoing or misuse of taxpayer dollars by Telescope Health, ending months of scrutiny over the Jacksonville company that operates the city’s HealthLink JAX program for uninsured residents.
Ad Performance And Politics Steered Brand Dollars Away From LGBTQ+ Communities – But The Pendulum Will Swing Back
The current administration discouraged many brands and organizations from supporting and marketing to the LGBTQ+ community, including in June
London Theatre Company, Including Bridge Theatre, Sold to Trafalgar Entertainment
The company has hosted recent revivals of Into the Woods and Guys and Dolls .
Nancy Pelosi's post-Congress plan: Launching UC Berkeley politics institute
Rep. Nancy Pelosi will launch a multimillion-dollar politics institute at UC Berkeley when she leaves office, co-teaching a course on Congress and hosting visiting fellows from across the political spectrum.
New Ballard coffee shop burglarized two months into business
Highland Espresso is recovering after thieves broke in and stole thousands of dollars worth of equipment early Thursday morning.
Employment scams study reveals soaring numbers
Job hunters tricked into handing over thousands of dollars are being lured with a new tactic: task-based scams, in which they are offered high pay to “like” and “subscribe” to videos online.
States seek to lower drug prices by targeting the companies that manage them for health plans
TOPEKA, Kan. — As consumers worry about medication costs, states are trying to lower drug prices by reining in big companies that oversee prescription coverage for health insurers. Some of those companies, called pharmacy benefit managers, also own pharmacies, and one of them, CVS, has spent millions of dollars fighting
Former Washington health care executive pleads guilty to $24 million wire fraud scheme
A former health care executive in North Central Washington has pleaded guilty to wire fraud after prosecutors say he siphoned tens of millions of dollars.
4 AI Prompts to Build a Profitable One-Person Business in 2026 (The Part Every AI Influencer Skips)
Spot the one move every AI influencer skips — and turn it into your next multimillion-dollar business.
Tourism tax dollars to drive $25M makeover of John R. Jones Sports Complex in Pensacola
PENSACOLA, Fla. -- The John R. Jones Sports Complex will soon undergo a makeover. When it's complete, it is expected to be one of the premiere athletic fields i
The Business of Grand Theft Auto VI, Explained: How a Billion Dollar Game Is Likely to Pay Off
Anthony Palomba on why the stakes are so high for the Grand Theft Auto VI launch and what it means for the gaming industry and the entertainment industry as a whole.
NASA's canceled Artemis hardware contracts reached $5.9 billion, audit finds
NASA was on track to pay nearly half a billion dollars for a stage adapter. A stage adapter should not cost half a billion dollars.
Should I Start A Business From Passion Or With The Intention To Sell?
Sara Blakely did not set out to build a billion-dollar company. She just wanted better underwear.
Dolly Parton makes surprise appearance — complete with a joke
Dolly Parton just made a surprise appearance, complete with her trademark humor, amid health issues.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Dolly Parton surprises fans at opening of her new travel stop amid ongoing health battle
Parton had to cancel her Las Vegas residency after announcing she was being treated for an undisclosed health issue.
Poppi founder speaks about building a billion-dollar soda business
Allison Ellsworth, the founder of the viral soda brand Poppi, sits down with NBC News' Savannah Sellers to discuss how she turned a personal health issue into a billion-dollar cultural phenomenon.
Dolly Parton Makes Surprise Appearance Following Health Issues
Dolly Parton made a surprise appearance at the grand opening of her travel stop in Tennessee just one month after she canceled an upcoming Vegas residency due to health concerns.
Mamdani and Hochul announce cash infusion for New York City Abortion Access Hub expansion
New York City and the Empire State are infusing hundreds of thousands of dollars into New York City Abortion Access Hub to expand its referral network
Walmart’s $1.4 billion Vibe.co deal is a direct shot at Amazon’s booming ad business
With a $1.4 billion deal for Vibe.co, Walmart is aiming to capture the ad dollars of smaller brands.
Las Vegas woman accused of running illegal multi-million-dollar healthcare scheme in Pearland, prosecutors say
Marizel Yukee is accused of providing medically unnecessary allografts to patients while receiving kickbacks, according to the U.S. Attorney’s Office. Her case is one prosecutors are citing as part of a national crackdown on health care fraud.
How to bet responsibly during the World Cup
With billions of more dollars and dozens of more games, this World Cup will be a bookmaker bonanza. Here's how to keep yourself safe while wagering.
Dartmouth Health reports $63.5 million loss at end of quarter
According to a recent filing, Dartmouth Health lost millions of dollars due to severe winter weather, inflation, and other challenges.
The Purpose Pivot: Activating Business Strategies to Reshape Systems
Our Purpose Pivot series continues with Ravneeta Consul ’06. As chief operating officer of Undue Medical Debt, Consul works on one of the most widespread and least visible financial burdens in the United States. The national nonprofit has abolished more than 40 billion dollars of medical debt for 27 million people across all 50 states, while also working to change how the system itself is understood and addressed.
House, Senate health chairs Creekmore and Bryan say rural health program, spending need more transparency
Senate Public Health Chairman Hob Bryan said the lack of transparency around the governor's program to spend millions in federal rural health dollars in Mississippi is "almost the Saturday Night Live parody of secrecy." Bryan and his House counterpart, Chairman Sam Creekmore, share their frustrations over lack of input from communities, and the Legislature, in how the state spends federal rural health care money.
Polls open as New Yorkers vote in several contested congressional races
Several contests feature open seats, high-profile endorsements and millions of dollars in campaign spending, making this one of the most consequential primary days in recent years.
Virginia legislators advance $205 billion budget including new tax on data centers
Virginia legislators approved a two-year, $205 billion budget proposal to fund healthcare and public education, provide 4% teacher raises and a 3.5% pay bump to state employees, establish a retail weed marketplace and hedge against decreased federal dollars.
Santana: Politician Spending Accounts Fuel Banana Republic Politics Across OC
Despite recent grand jury warnings, OC Supervisors tomorrow are ready to vote to keep spending and creating multi-million dollar, taxpayer-funded discretionary spending accounts.
Register now for even bigger Run Dollywood race weekend this fall
Runners who want to join in the glittery fun of the second Run Dollywood race weekend - set for this fall - might want to register soon to get a spot.
Exclusive: Trump administration uses homeland security funds to force states into election changes
The Trump administration is threatening to withhold tens of millions of dollars in federal homeland security funds from states unless they adopt a sweeping set of election changes, according to multiple sources and internal documents obtained by CNN.
Road to cannabis cafes is long and painful for weed businesses
Cannabis entrepreneurs have sunk lots of dollars into weed cafes, but now they're waiting for towns and state officials to let them move forward.
Conservatives spent heavily in key Democratic primaries, filings show
An influential conservative nonprofit covertly funded a series of super PACs with names suggesting liberal provenance as the groups injected hundreds of thousands of dollars into key nominating Democratic contests across the country.
How the WNBA went from survival mode to a billion-dollar future
As the WNBA celebrates its 30th anniversary, the once-fledgling league has evolved from its 1997 launch into a global fixture in women’s sports.
Iranian Guard’s business empire to win big if U.S. sanctions lifted
As the two sides eye a deal to end the war that could unlock billions of dollars for Iran, the elite Revolutionary Guard is poised to be one of the biggest beneficiaries.
Accenture Just Had Its Worst Day in Years. Is AI Coming for the Consulting Business?
The consulting giant posted solid results, yet a cautious outlook and a multibillion-dollar acquisition bet sent its stock to the lowest level in years.
Microsoft (MSFT) Is Building A Billion Dollar AI Business In China
Microsoft (NasdaqGS:MSFT) is building a large AI and cloud business in China, supplying OpenAI models through Azure to major local technology companies. ByteDance is reported to spend over US$1b annually on Microsoft AI and cloud services, with Ant Group, Meituan, and Tencent also using Microsoft models. Microsoft has emerged as a key provider of OpenAI technology in China at a time when several US competitors are not active in the region. For investors watching Microsoft, this growing AI...
New Kentucky athletics director J Batt's focus on dollars make sense
Kentucky's J Batt hire reflects a trend in college sports where athletics directors function like CEOs and wins are measured by financial success.
Juneteenth celebration brings $35,000 in grants to Columbus small businesses
A Juneteenth celebration in Columbus brought people together and put thousands of dollars into local businesses.
East Prairie High School receives grant to restore agri-science center greenhouse
East Prairie High School is receiving help to restore its greenhouse after severe weather caused thousands of dollars in damage earlier this year.
USF marine science research destroyed in St. Pete lab fire caused by lightning strike
A lightning strike sparked a devastating fire at the USF College of Marine Science Lab last month, destroying decades of critical research and tens of millions of dollars in equipment in St. Petersburg.
Report: Invoices show ballroom cost rose to $600 million, more than half from tax dollars
U.S. Sues N.Y. State Over Troubled $11 Billion Home Health Care Program
The Justice Department accused officials of failing to police a vendor it said had siphoned off millions of dollars. A spokeswoman for Gov. Kathy Hochul called the suit an attempt to weaponize the justice system.
Merchants of Doubt and the attacks on Extreme Event Attribution science
Last week, I attended a meeting at Columbia University on attribution science and climate law, hosted by the Sabin Center. It was a fantastic event, bringing together scientists and legal experts working at the intersection of extreme event attribution and climate law. Subscribe For those unfamiliar with it, extreme event attribution attempts to quantify the contribution of climate change to an extreme event. For example, several groups analyzed the impact of climate change on Hurricane Harvey’s enormous rainfall totals over Houston, Texas and they found that climate change increased rainfall by 15 to 38%. One thing that came up again and again was how terrified fossil-fuel interests are of extreme event attribution science. They are acutely aware that this research could land them in court. And losing those cases would leave them legally liable for billions of dollars in climate damages. Because the legal stakes are so high, the blowback has turned ugly. I spoke with several scientists at the meeting who are facing ongoing harassment over their work. This blowback is a coordinated campaign to make the entire field look suspect. The goal is to create the impression that attribution science is too uncertain, too political, or too conflicted to be useful in court or in public policy. The strategy is not based on actual science or evidence of misconduct, but on the generation of doubt. The new Merchants of Doubt We’ve seen this before. In fact, not that long ago: We only have to go back a year to the Department of Energy (DOE) Climate Working Group (CWG) report to see an example of using doubt as the tool to push back against well-established science. This strategy is laid out in an email from a member of the CWG, Dr. Roy Spencer, that was released during litigation over the Climate Working Group process. The key quote is: About all I can hope is that what we write will provide sufficient “reasonable scientific doubt” regarding the science claims in the 2009 TSD [technical support document], based upon almost 2 decades of new science, to call into question the original reasoning for the EPA Administrator’s decision that CO2 presents a threat to human health and welfare. This statement is strong evidence that at least some members of the committee were working to support a particular policy outcome: revoking the Endangerment Finding. The email also explains how they planned to do it: by attempting to generate “reasonable doubt”. This is going to be hard, Spencer implies. Despite falsely claiming that “2 decades of new science” weakens the case, Spencer explicitly acknowledges that the actual peer-reviewed science of climate change overwhelmingly rejects his position: But if the science argument is decided upon by a vote, or by the number of published citations, we lose the science argument. We can go back even further: This CWG email shares unmistakable DNA with the infamous 1969 tobacco memo that declared: “Doubt is our product, since it is the best means of competing with the ‘body of fact’ that exists in the mind of the general public. It is also the means of establishing a controversy.” The tobacco memo also acknowledges the limit of this strategy: Like the CWG, they knew the science was not on their side. Share The new new Merchants of Doubt The people attacking the IPCC chapter on extreme event attribution are the newest iteration of the Merchants of Doubt. Their goal, like all Merchants before them, is to introduce doubt into the process. Because the report is not even out yet, they cannot attack its conclusions. So they are attacking the authors instead. Here is a press release from the House Science, Space, and Technology Committee: In the letter, the Chairmen express concerns about potential conflicts of interest involving members of the Attribution Committee, stating that “publicly available information suggests a troubling pattern” in which committee members are affiliated with nonprofits that support climate accountability lawsuits, “raising the appearance of impropriety and member bias.” To be clear, this is just innuendo. There is no actual evidence of bias. And given the robust process that these reports go through, including multiple lines of peer review, it seems very unlikely that significant bias can survive into the report. When the report comes out, critics will have the opportunity to make legitimate criticisms of the report — if any exist. If none do, however, they’ll still make criticisms, but they’ll be bogus, simply designed to generate doubt. We’ll see. A note to the press: Fix your frame To any journalists reading this: The public debate over extreme event attribution science is not going away. The science is simply too dangerous to fossil-fuel interests for them to stop fighting it. You very well might be assigned to write an article about this area of research in the future. When you do, do not automatically adopt the framing that climate misinformers want you to use. They want you to frame the story around questions like: Are climate scientists trying to put their thumb on the scale to achieve a predetermined, politically motivated result? Are climate scientists improperly letting their politics invade the science of the IPCC? That frame is a trap. Instead, you need to view this through the historical lens of the Merchants of Doubt. How does the ecosystem of doubt operate? Who funds it? What methods do they use to misrepresent science and slime researchers? What scientific results are they trying to keep people from understanding are legitimate? Ultimately, you instead need to focus your article on the generation of doubt as a way to maintain the fossil fuel industry’s social and legal license to keep burning oil, gas, and coal. If you treat the misinformers’ frame as a legitimate, good-faith scientific critique, you are helping them produce doubt. Don’t do it. Don’t be a Merchant of Doubt. Thanks for reading The Climate Brink! Subscribe for free to receive new posts and support our work. Subscribe other stuff The Staying Curious Substack has an interesting post about the different flavors of climate sensitivity. This is crucial information if you want to understand how scientists think about how much warming the Earth will experience. I’d be grateful if you could hit the like button ❤️ below! It helps more people discover these ideas and lets me know what’s connecting with readers.
Ohio bill would ban use of politicians’ names, images on publicly funded signage
COLUMBUS, Ohio (WCMH) – Two Ohio lawmakers are attempting to ban the use of taxpayer dollars for political branding on public signage, such as road signs. Reps. Mark Hiner (R-Howard) and Tex …
Baker leaders, BREC propose multimillion-dollar investment in youth sports facilities
City leaders and BREC officials are moving forward with plans to invest millions of dollars into youth sports facilities in Baker.
Nearly half a billion dollars in ads projected in Maine election
Most of the spending will target the crucial U.S. Senate race between Democrat Graham Platner and Republican Susan Collins, according to AdImpact.
Microsoft sued by shareholders over expenses, cloud business, AI
Microsoft has been sued by shareholders who accused the company of defrauding them and inflating its stock price by failing to disclose slowing growth in its Azure cloud business and the need to spend billions of dollars on AI infrastructure.
Microsoft sued by shareholders over expenses, cloud business, AI
Microsoft has been sued by shareholders who accused the company of defrauding them and inflating its stock price by failing to disclose slowing growth in its Azure cloud business and the need to spend billions of dollars on AI infrastructure. The proposed class action led by a Michigan pension fund was filed in Seattle federal court on Friday, after Microsoft shares fell 10% on January 29 in response to its quarterly earnings report a day earlier. About $357 billion of market value was erased, and Microsoft's stock suffered its biggest one-day decline in nearly six years.
What Will It Take to Get a Bundibugyo Vaccine? | Johns Hopkins Bloomberg School of Public Health
Decades of research and billions of dollars went into licensing a vaccine for Zaire ebolavirus. What will it take to get one for Bundibugyo?
Electronic Arts Makes Push for Ad Dollars Tied to Sports
Electronic Arts Makes Push for Ad Dollars Tied to Sports
Colts Star Next to 'Break the Bank' and Reset Market
The Indianapolis Colts have a top-dollar contract extension to consider in the near future.
Trump litigation has helped lift AG Campbell's political star
Attorney General Andrea Campbell has sued the federal government more than 50 times since President Trump took office, using millions of dollars in extra taxpayer funding to help form the state-level bulwark that, more often than not, has won in court.
Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds
The National Bureau of Economic Research paper's lead author hopes putting a dollar value on the benefits of GLP-1s will lead to better access
Vintage Coach briefcases are now the 'it' work bags
People are paying hundreds of dollars for vintage Coach briefcases they can carry to work. A modern version of the Metropolitan bag is also sold out.
I visited Dollar General for $1 groceries. Here's what stood out.
Dollar General is adding more $1 items to its shelves, including food. I went to see what the selection looks like and saw its loss-leader strategy.
Political blame game follows as screwworm parasite threatens cattle in Texas
Screwworms are on their way to becoming a billion-dollar international problem but can be contained if ranchers are vigilant, watch their herds and other wildlife, and quickly treat any infestations, U.S. Agriculture Secretary Brooke Rollins said.
The Obama Presidential Center was meant to lift up local contractors. Some are now fighting for survival.
Some subcontractors on the $850 million project say they are being pushed to the financial brink as they quietly fight to collect millions of dollars in unpaid bills.
Dolly Parton affiliated entertainment complex proposed in Panama City Beach
PANAMA CITY BEACH, Fla. (WMBB) – A new family entertainment attraction could be coming to the space next to Pirates Voyage Dinner & Show in Panama City Beach. A Dolly Parton affiliated co…
Dolly Parton affiliated entertainment complex proposed in Panama City Beach
PANAMA CITY BEACH, Fla. (WMBB) – A new family entertainment attraction could be coming to the space next to Pirates Voyage Dinner & Show in Panama City Beach. A Dolly Parton affiliated co…
Sports betting popularity in Ohio continues to climb amid World Cup, NBA Finals
It's been more than three years since sports betting became legal in Ohio. It's now a multibillion-dollar industry in the Buckeye State.
Big dreams and even bigger possibilities possible with Science Museum Oklahoma's Barbie experience
Science Museum Oklahoma has a brand-new exhibit celebrating an iconic doll that has inspired children to imagine big through her many careers.
He Spent 15 Years Amassing SpaceX Shares. Now Comes the Windfall.
Justin Fishner-Wolfson, long a minor figure in Elon Musk’s orbit, is at the helm of a multibillion-dollar payout
Xbox layoffs planned as CEO Asha Sharma orders business reset
The Microsoft gaming unit's accountability margin has fallen to 3%, and revenue declined nearly half a billion dollars over five years
Political reviews are causing a huge grant backlog at the National Park Service
Hundreds of millions of dollars in National Park Service funding is sitting in limbo at the Department of Interior, awaiting a political review that longtime agency staff say has put a stranglehold on the agency’s work.
Hiltzik: The Diabetes Association crosses a line
The tally from Trumpian attacks on science now includes billions of dollars in damage to farmers and ranchers and assaults on scientists' freedom of speech.
Inside the war to sideline stronger climate science, before it’s used in court
An emerging field of research that can measure how much climate change has worsened individual disasters is under attack by friends of the fossil fuel industry. Billions of dollars are at stake.
Taking Wing: Juan Sanchez
The Jays’ International Free Agent pipeline has been a bit down in recent years. Vladimir Guerrero jr. and Alejandro Kirk are homegrown stars who signed at 16, but they’re it on the roster right now. There isn’t a ton of immediate promise on the farm, either. Recent top dollar signings, including like Manuel Beltre, Luis […]
Chiefs rework Patrick Mahomes' contract as quarterback becomes NFL's first half a billion dollar player
With the new deal that runs through 2033, Mahomes will earn an NFL-best $64 million per year
Scientists, higher ed alarmed by federal 'power grab' over research funding
The Trump administration has proposed regulations to control billions of dollars in federal research funding, which it says will reduce "fraud and abuse." Scientists in Massachusetts and beyond say they could set back research in the U.S. by decades.
Xbox Boss Says a Mass Audience Can't Afford 'Thousands of Dollars' to Spend on a Next-Gen Console, So Microsoft Must 'Look at New Business Models'
The spiralling cost of new and existing consoles will require "radically different business models" over the coming generation, Xbox boss Asha Sharma has said.
New OMB rule could break science in the United States
The drug that saved your mother. The treatment your doctor recommended. The clinical trial that bought someone you love more time. None of it was inevitable. It required a system built to operate outside politics and sustained over decades, because science doesn’t operate on the timeline of a politician. That system is now under direct threat. The Office of Management and Budget (OMB) has proposed a new rule to regulate all federal grants, not just science, but housing, education, defense, NASA and everything in between, that would fundamentally change how research is conducted in the United States. There have been a lot of fires in the past 16 months, and if everything is an emergency, nothing is an emergency. But this is a very big deal. These rules would strip away the independence that has kept science from becoming a political tool. The good news is there’s still something we can all do. How the grant system was designed to work When I was a new faculty member, I was full of millions of ideas, so I sat down and wrote an NIH proposal. I worked on it for months and thought it was so good. Then I sent it to my mentor. It came back covered in comments. Places where my reasoning wasn’t as airtight as I’d thought, methods that could be stronger, gaps in my thinking that I had been too close to the work to see. It stung, as honest feedback always does, but peer review almost always makes the work better. In fact, it’s the backbone of how American science has functioned for generations. At NIH, submitted proposals go to a panel of scientists who have experience in the field. These are the people who can read research methods and spot their weaknesses, who understand when an experiment is designed well and when it isn’t. Applications are scored rigorously, and often only the top 3-20% of proposals receive funding. The people making funding decisions are required to justify them based on these reviews. To be clear: this is not a perfect system, and good science still goes unfunded more often than any of us would like due to limited resources. There is also criticism that peer review may undervalue bold ideas that are risky but could have high payoffs. But the peer review system is nonetheless a meaningful part of the grant selection process. While thoughtful and careful changes could improve the system, the changes being proposed by OMB will not make things better. The rule that could change everything Through this OMB proposal, the system that helps decide what gets funded is being dismantled. There are many troubling elements buried in this proposal, but three provisions stand out in particular. Each would be damaging alone. Together, they would change what kind of science gets done in America, and who it serves. 1. Political appointees would decide which science gets funded, and peer review would be explicitly sidelined or ignored. The guidelines your doctor follows, the standards that determine what’s in your air and water, the drugs that get approved for your family: all of it starts with a funding decision. Right now, that decision is made by scientists who can evaluate whether the work is actually sound and whether it could move the needle forward. Under this proposal, funding decisions could be made by political appointees. The careful, expertise-driven review process that shapes grant funding would be effectively sidelined. That means that a poorly designed study could get funded simply because someone in a political office liked the sound of it, while rigorous, important work doesn’t get funded because it no longer aligns with the administration’s priorities. In other words, critical work that benefits all of us could now be missed just because it has become politically inconvenient. 2. Grants could be canceled at any point, without warning, in the middle of ongoing work. Say your tax dollars have been paying for a cancer study for two years. The grant was awarded for five years, so the team is mid-experiment. There are three additional years’ worth of answers that could change how the disease is treated for hundreds of thousands of people. With this new rule, the federal government could cancel the remaining funding tomorrow, walk away from the commitment it made with your money, and have no legal obligation to finish what it started. This is a huge waste of money. There are rarely other sources of funding for this work, which means the team, the graduate students, postdocs, and research staff who have dedicated years of their careers to this project could lose their jobs. Patients who have contributed their time to studies may not see it turn into useful learnings for others. Every hour of work already completed could result in nothing useful. Science can take decades to get to tangible outcomes. It needs a stable funding system to flourish. 3. Researchers would have a harder time communicating their findings without pre-approval from the federal government. There is a saying from Sir Mark Walport: “Science isn’t finished until it’s communicated.” Science is no use to anyone if it is kept locked away in the labs that produced the data. The proposed rule could make communicating research findings harder in a number of ways: Make it harder for scientists to widely share their findings in scientific journals. Publication costs, including journal fees that allow for broad public access, could not be paid for by federal funds which is often how scientists pay these costs. Restrict researchers from engaging publicly about how their findings should inform policy or public health guidelines. This would restrict scientists from doing the work that transforms years of lab work into decisions that actually affect people’s lives. Make it harder for scientists to attend conferences. Conferences would now need to be approved by the federal agency at the time of grant award. This disadvantages conferences or publications that are not politically aligned. Conferences are a key way in which scientists learn about work happening in their field so they can collaborate and build on each other’s findings. What good is science with a muzzle? The long-term impact These changes could (and hopefully would) be reversed under the next administration. But by then, damage has been done. Once projects are halted or denied funding by political appointees, people leave their science careers for other paths or even leave the country to do their amazing science elsewhere. You cannot pause a scientific study the way you pause a subscription you decided isn’t useful anymore. You cannot freeze a research team that depends on salaries to feed their families, causing a scramble for replacement funding that, in most cases, simply does not exist. When the money stops, everything stops, and all the work in progress and its potential are lost. Despite all of the language about reducing waste, fraud, and abuse, this new proposed rule increases the administrative burden tremendously. Every researcher watching this unfold will make a rational decision: don’t start anything that will take a decade to finish. This includes not building a team around funding that could vanish, or asking the big questions that need patience and stability to answer. The most consequential science, the kind that produces the treatments and the breakthroughs that reach your doctor’s office twenty years from now, is exactly the science that would be abandoned first. This is still a proposal, so we can all do something Some worry this rule is already a done deal. But by law, OMB is required to open a public comment period. Those comments matter because they inform members of Congress, they can be used in litigation, and they create a public record. So here’s what you can do: Submit a public comment. The public comment period on this proposed change is open until July 13. Anyone can submit a comment, and OMB is required to respond to substantial ones. Each comment must be different to count as distinct; identical comments will be counted only once. Comment as an individual, not on behalf of your organization. Here’s a full resource to help you, with useful examples, but in general: Share a story about how science or federal funding has benefitted you or is involved in your work. Are you or someone you loved a cancer survivor? Do you know someone with Alzheimer’s? Have you received NIH/NSF or other federal funding? All of these can be stories you use to highlight why you care. Explain why you’re worried about these proposed changes. You can use the wording found here or in other resources to help you. Ask them to withdraw this proposed rule. Contact your elected representatives. Congress allocates money to federal agencies to spend, and it has oversight of how that process works. You can let your representatives know this proposed change concerns you and ask them to intervene. There are levers they can push that can help at this moment. Let others know why federal funding matters. This isn’t just about science, but ALL federal grants, including for education systems, defense projects, and more. The process, including the importance of federal funding, is invisible to many. We can all make it more visible by sharing how science benefits us and why we value it. You can also share this article, or any of the resources linked here, to help spread awareness! Bottom line We are quickly losing ground in scientific research in the U.S. More changes, like the proposed rule by OMB, would decimate our ability to conduct research here, leaving us all worse off: fewer treatments for pancreatic cancer, less research on pollution impacts, fewer answers for patients with rare disease, and more unaddressed health needs. The impact will be very real for all of us, regardless of where we stand politically. Using our voices for science is more important than ever. Love, LM Big thanks to Dr. Megan Ranney for reading this over and providing brilliant insights, as always. Dr. Liz Marnik, PhD, is Executive Director of The Evidence Collective at YLE and a science communicator and immunologist working at the intersection of public trust, science, and public health. You can find her on Substack, LinkedIn, Instagram and Threads. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Mother and daughter learn to live again in "Honeyjoon"
“Laughter through tears is my favorite emotion,” Truvy Jones (Dolly Parton) said in “Steel Magnolias.” First-time feature film director Lilian T. Mehrel applies that notion to her film “Honeyjoon.” What
Politics: The State Of LGBTQ+ Rights In 2026
Across the U.S., cities and communities are celebrating Pride during the month of June.At the same time, a new poll from Gallup suggests attitudes around LGBTQ issues are shifting. After two decades, support for the community has now dropped. The swing is being largely driven by republicans. Just four years ago, polling data suggested a majority of Republicans supported same sex marriage at 55 percent. That number is now at 37 percent.Trans issues, specifically, is another story. Only 5 percent of Republicans say changing one’s gender is morally acceptable. That number was at 22 percent five years ago.Trans rights in the U.S. are a hot button issue among conservative politicians and voters. President Donald Trump campaigned on it, spending millions of dollars on anti-trans ads. Since then, the administration has rolled back protections for and access to gender-affirming care.What is the state of LGBTQ+ rights in the U.S. today? And what does this reported dip in acceptance mean for the community?Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Can California afford to cover Ozempic for public employees?
California may require CalPERS health plans to cover Ozempic and other GLP-1 weight-loss drugs. The insurer warns it would cost hundreds of millions of dollars.
Weapon Systems Acquisition: Beyond Business as Usual—Using Leading Practices to Curb Waste and Save Billions
Since 1990, DOD’s costliest weapon programs have consistently exceeded cost estimates and delivery schedules—wasting billions of dollars and decades...
Why this teen founder walked away from his multimillion-dollar company
MyFitnessPal acquired Cal AI, an AI-powered calorie-tracking app that 19-year-old Zach Yadegari cofounded while he was in high school, last year.
Alaskans Reel From the Loss of National Science Foundation Ocean-Monitoring Instruments
In the nation’s fastest-warming state with a multi-billion-dollar fishing industry and storm-threatened coastal communities, scientists say the federal government’s decommission of a deepwater sensor system is ill-timed and wrong-headed.
Big spending by Super PACs in congressional primaries
Millions of dollars have already been spent by outside groups known as Super PACs to try to sway voters in the upcoming congressional primaries
The iOS 27 Beta Pretty Much Confirms That An Apple Foldable Is Happening
Can’t a multi-trillion-dollar company have secrets any more?
'City is shooting us down': Stuart business owner speaks out on costly permit delays
A business owner says a permit for a storage building has turned into a nearly 2-year battle with the city, costing her thousands of dollars and leaving her frustrated with the permitting process.
How PE Guy became a million-dollar business in just a year
Johnny Hilbrant's joke parodying annoying finance bros has become a hit. They would be shocked by how much he makes off of "silly little skits."
Our health insurance network adds costs without adding value: Dr. Fieseher
Dr. Fieseher: A health insurance network is not the same as a healthcare system and Americans are paying the price in dollars and their health.
A complicated funding tool helps a West Central business make public investments
A West Central business trying to build an oasis in the neighborhood’s food desert will receive nearly a quarter-million dollars in public funding through a decades-old mechanism that is only just recently starting to pay dividends.
Race to Erase MS Gala Honors Disney's Naomi Bulochnikov
Ty Dolla $ign, Richie Sambora and Rachel Platten performed at the 33rd Race to Erase MS Gala, which raised more than $1.8 million.
Hanover County grandmother turned pre-Civil War recipe into multi-million dollar business
Lillie Pearl Fearnow turned a pre-Civil War family recipe into Fearnow’s Brunswick Stew, a product that became a staple in pantries across the south.
Livid dog trainer customers say they paid thousands to SE Michigan business
Customers across Southeast Michigan say they were left out thousands of dollars after paying for dog training services they claim were never provided by Great Lakes Dog Training.
Trump’s troop reversals in Europe could cost taxpayers millions, officials say
The U.S. military is waiting for clarity from the Pentagon following President Donald Trump's back-and-forth on troop levels in Europe, upending the lives of military personnel and potentially costing taxpayers millions of dollars, two U.S. defense officials told The Associated Press.